Antiplatelet treatment imaging test for stroke patients
Part of Blood & lymphatic, Brain & nervous system, Heart & circulation clinical trials.
This study uses special microscope imaging (transmission electron microscopy) to look at tiny changes in platelets before and after starting an antiplatelet medicine. It’s testing whether platelets show clear structural signs around the start of treatment for a specific type of stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have health coverage through the social security system
- You can sign informed consent to join the study
- You are currently hospitalized for a non-cardioembolic ischemic stroke
- Your stroke care team plans to start antiplatelet therapy soon (following usual guidelines)
- You do not have a known allergy or medical reason to avoid the antiplatelet drug(s) being used
- You also do not have a known reaction risk to the drug’s inactive ingredients (excipients)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological and imaging markers that may predict heart/vascular outcomes after an ischemic stroke. You may join if you are eligible for standard stroke treatment and can complete planned follow-up and MRI scans.
This study looks at tiny blood clots and immune cell activity in people with or without a recent stroke. It aims to find markers that could predict stroke risk or help improve treatment.
This trial looks at how anti-clotting medicines affect small blood vessel bleeds in the brain (cerebral microbleeds) and larger bleeding in the skull after an ischemic stroke. It may help doctors choose safer prevention medicines for people who already have these small bleeds seen on brain MRI.
This study looks at whether certain blood tests can predict if the antiplatelet drug clopidogrel (Plavix) will work well in people who have had a mild stroke or a mini-stroke (TIA). The goal is to help doctors choose the best treatment for each person.
This trial uses a special imaging technique to check if blood flow has fully returned to the brain after a stroke clot is removed. It aims to improve understanding of how well the brain's tiny blood vessels are working after treatment.
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.